Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 2,340† | 2,102† | 2,163† | 2,243† | 2,216† |
| Net profit | 138 | 101 | 135 | 140 | 166† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Abhiraj Gupta | Executive Director | June 30, 2026 |
| Kushal Kumar Rana | Executive Director | June 30, 2026 |
| Varinder Gupta | Executive Director | June 30, 2026 |
| Vikas Gupta | Executive Director | June 30, 2026 |
| Harpal Singh | Independent Director | June 30, 2026 |
| Rajender Mohan Malla | Independent Director | June 30, 2026 |
| Rajni Jha | Independent Director | June 30, 2026 |
| Sharad Tyagi | Independent Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
